Skip to main content
Equibles

ALGERT GLOBAL LLC

Position in VERU — Veru Inc.

CIK 1275218 SAN FRANCISCO, CA
Back to VERU Full portfolio

Position in VERU

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$131,910
+$69,855 QoQ
Shares Held
42,144
+3179.7% QoQ
Ownership
0.247%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 61 holders
Holding Since
Mar 2022
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VERU Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ALGERT GLOBAL LLC holds $633,232,925 across 110 Biotechnology names. VERU ranks #107 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PCVX
Vaxcyte, Inc.
 515,343 $29,956,888
2 ROIV
Roivant Sciences Ltd.
 845,118 $29,908,726
3 XENE
Xenon Pharmaceuticals Inc.
 419,773 $25,337,498
4 CLDX
Celldex Therapeutics, Inc.
 647,836 $24,105,977
5 AXSM
Axsome Therapeutics, Inc.
 95,335 $23,335,147
6 SNDX
Syndax Pharmaceuticals Inc
 1,051,465 $22,985,024
7 MRNA
Moderna, Inc.
 274,820 $19,245,644
8 MLYS
Mineralys Therapeutics, Inc.
 649,027 $17,510,748

All Filings in VERU

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $131,910 42,144
2022-03-31 $62,055 12,848